<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0"/>
  <title>Finding Dopa – Scientific Insights</title>
  <link href="https://fonts.googleapis.com/css2?family=PT+Serif&family=Orbitron:wght@500&display=swap" rel="stylesheet">
  <style>
    body {
      margin: 0;
      font-family: 'PT Serif', serif;
      background: linear-gradient(to bottom, #0c0f1c, #1b203a);
      color: #eaeaea;
      line-height: 1.6;
    }

    header, footer {
      background: #0a0c14;
      padding: 20px;
      text-align: center;
      font-family: 'Orbitron', sans-serif;
      color: #90e0ef;
      border-bottom: 2px solid #3a3f5c;
    }

    h1 {
      margin: 0;
      font-size: 2em;
    }

    .container {
      max-width: 960px;
      margin: 40px auto;
      padding: 0 20px;
    }

    .section-title {
      font-family: 'Orbitron', sans-serif;
      font-size: 1.6em;
      color: #00f5d4;
      margin-top: 60px;
      margin-bottom: 20px;
    }

    p {
      margin-bottom: 20px;
    }

    a {
      color: #ffcc00;
      text-decoration: none;
    }

    a:hover {
      text-decoration: underline;
    }

    .science-block {
      background: rgba(255, 255, 255, 0.05);
      border-left: 5px solid #00f5d4;
      padding: 20px;
      margin-bottom: 40px;
      border-radius: 5px;
    }

    .cta {
      text-align: center;
      margin-top: 60px;
      font-family: 'Orbitron', sans-serif;
    }

    .cta a {
      background: #00f5d4;
      color: #000;
      padding: 12px 24px;
      border-radius: 5px;
      font-weight: bold;
    }
  </style>
</head>
<body>

  <header>
    <h1>Finding Dopa</h1>
    <p>A fix for Parkinson’s Disease is on the way. Keep fighting!</p>
  </header>

  <div class="container">
    <div class="science-block">
      <h2 class="section-title">Understanding Cell Therapy in Parkinson's</h2>
      <p>
        Parkinson’s Disease (PD) is marked by the degeneration of dopaminergic neurons in the substantia nigra. One approach to reversing this involves transplanting cells that can replace the lost neurons and restore dopamine production.
      </p>
      <p>
        Sources of these cells include fetal midbrain tissue, embryonic stem cells, induced pluripotent stem cells (iPSCs), and mesenchymal stromal cells (MSCs). Each source has benefits and risks, particularly concerning immune response, ethical considerations, and scalability.
      </p>
    </div>

    <div class="science-block">
      <h2 class="section-title">Mesenchymal Stromal Cells (MSCs)</h2>
      <p>
        MSCs offer immunomodulatory benefits and can be harvested from adult tissues like bone marrow, adipose tissue, and umbilical cord. In PD, MSCs are explored not just for their regenerative properties but for their ability to deliver neuroprotective factors.
      </p>
      <p>
        Ongoing trials are investigating their safety and efficacy. Results so far suggest MSCs are well-tolerated, with potential to slow disease progression.
      </p>
    </div>

    <div class="science-block">
      <h2 class="section-title">Clinical Trial Insights</h2>
      <p>
        Several clinical trials are underway assessing stem cell therapies in PD. While earlier fetal tissue trials showed variable outcomes, newer approaches using iPSCs or MSCs are more standardized and ethically sound.
      </p>
      <p>
        For example, Takahashi et al. in Japan have successfully transplanted dopaminergic neurons derived from iPSCs in a PD patient, showing promise for long-term integration and function.
      </p>
    </div>

    <div class="science-block">
      <h2 class="section-title">Key Challenges</h2>
      <p>
        Major hurdles include ensuring the cells survive post-transplant, integrate functionally with host brain tissue, and do not cause immune rejection or tumor formation. Long-term monitoring and refinement of delivery techniques remain essential.
      </p>
    </div>

    <div class="cta">
      <p>Learn more and join the fight:</p>
      <a href="#clinical-trials">Explore Clinical Trials</a>
    </div>
  </div>

  <footer>
    <p>&copy; 2025 Finding Dopa. All rights reserved.</p>
  </footer>

</body>
</html>
